These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16448798)

  • 1. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
    Segura MM; Kamen A; Garnier A
    Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
    Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
    Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of retrovirus particles using heparin affinity chromatography.
    Segura MM; Kamen A; Garnier A
    Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
    Sinn PL; Sauter SL; McCray PB
    Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of retroviral vectors for clinical application: biological implications and technological challenges.
    Rodrigues T; Carrondo MJ; Alves PM; Cruz PE
    J Biotechnol; 2007 Jan; 127(3):520-41. PubMed ID: 16950534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-engineering of lentiviral vectors.
    Verhoeyen E; Cosset FL
    J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors in clinical trials: Current status.
    D'Costa J; Mansfield SG; Humeau LM
    Curr Opin Mol Ther; 2009 Oct; 11(5):554-64. PubMed ID: 19806504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular trafficking of retroviral vectors: obstacles and advances.
    Anderson JL; Hope TJ
    Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the isolation and purification of retroviral vectors for gene therapy.
    Braas G; Searle PF; Slater NK; Lyddiatt A
    Bioseparation; 1996; 6(4):211-28. PubMed ID: 9032984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaleable purification process for gene therapy retroviral vectors.
    Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE
    J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vectors: progress and potential.
    Lever AM
    Curr Opin Mol Ther; 2000 Oct; 2(5):488-96. PubMed ID: 11249751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviruses in gene therapy clinical research.
    Connolly JB
    Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
    Breckpot K; Aerts JL; Thielemans K
    Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale production means for the manufacturing of lentiviral vectors.
    Schweizer M; Merten OW
    Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and purification of lentiviral vectors.
    Tiscornia G; Singer O; Verma IM
    Nat Protoc; 2006; 1(1):241-5. PubMed ID: 17406239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
    Segura MM; Kamen A; Trudel P; Garnier A
    Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral vectors: are they the future of animal transgenesis?
    Park F
    Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vectors for HIV disease prevention and treatment.
    Lemiale F; Korokhov N
    Vaccine; 2009 May; 27(25-26):3443-9. PubMed ID: 19201386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.